| NAME OF THE PROJECT | : Omeprazole |
| PRODUCT NAME | : Omeprazole EP Impurity - I |
| CODE & CAT NO | : LP - 2100-03-005 |
| MOLECULAR FORMULA | : C17H19N3O5S |
| MOLECULAR WEIGHT | : 377.41 |
| CAS NO | : 158812-85-2 |
| CHEMICAL NAME | :4-methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide |
| CAT NO | : LP - 2100-01-001 |
| CAS NO | : 73590-58-6 |
| Mol.F | : C17H19N3O3S |
| Mol.Wt. | : 345.42 |
| CAT NO | : LP - 2100-03-002 |
| CAS NO | : 37052-78-1 |
| Mol.F | : C16H17N3O2S |
| Mol.Wt. | : 315.39 |
| CAT NO | : LP - 2100-03-004 |
| CAS NO | : 73590-85-9 |
| Mol.F | : C17H19N3O2S |
| Mol.Wt. | : 329.42 |
| CAT NO | : LP-2100-03-001 |
| CAS NO | : 88546-55-8 |
| Mol.F | : C17H19N3O4S |
| Mol.Wt. | : 361.42 |
| CAT NO | : LP - 2100-03-007 |
| CAS NO | : 76219-04-8 |
| Mol.F | : C17H19N3O4S |
| Mol.Wt. | : 361.41 |
| CAT NO | : LP - 2100-03-008 |
| CAS NO | : 119141-89-8 |
| Mol.F | : C17H19N3O3S |
| Mol.Wt. | : 345.42 |
| CAT NO | : LP-2100-03-003 |
| CAS NO | : 110374-16-8 |
| Mol.F | : C16H17N3O2S |
| Mol.Wt. | : 315.39 |
| CAT NO | : LP - 2100-03-005 |
| CAS NO | : 158812-85-2 |
| Mol.F | : C17H19N3O5S |
| Mol.Wt. | : 377.41 |
| CAT NO | : LP - 2100-03-001 |
| CAS NO | : 88546-55-8 |
| Mol.F | : C17H19N3O4S |
| Mol.Wt. | : 361.42 |
| CAT NO | : LP - 2100-03-002 |
| CAS NO | : 37052-78-1 |
| Mol.F | : C16H17N3O2S |
| Mol.Wt. | : 315.39 |
| CAT NO | : LP - 2100-03-007 |
| CAS NO | : 176219-04-8 |
| Mol.F | : C17H19N3O4S |
| Mol.Wt. | : 361.41 |
| CAT NO | : LP - 2100-03-009 |
| CAS NO | : 86604-75-3 |
| Mol.F | : C9H12CINO.HCl |
| Mol.Wt. | : 222.11 |
CATEGORY : Omeprazole
TOTAL PRODUCTS : 12
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
